Share to linkedin
DNA sequencing was still very expensive and rare at the time, but Mangubat and her cofounders at Spiral Genetics anticipated a day when the cost of sequencing a genome would drop enough to allow scientists to sequence hundreds of thousands or millions of human genomes, whole populations, and compare them to learn about disease. To analyze such a volume of data, with the technology of the time, would have been prohibitively difficult and time-consuming, Mangubat predicted.
But a year after the acquisition, Mangubat says she felt the focus of the company shift from the population-level analysis she had in mind when she founded the company to the clinical market of analyzing individual patient genomes. Now, Mangubat is relaunching Spiral as a separate company focused on comparing the whole genome data of large populations after taking it through Y Combinator’s latest accelerator session.
AOC should take lessons from this great and successful young lady. Great for her and for CAPITALISM!
IMFNews
Technology Technology Latest News, Technology Technology Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »